Home - About Us - News - Events - news

Exhibition Report | ADLM Debut Concludes Successfully


July 28 – August 1, 2024 The 76th Annual American Association for Clinical Chemistry (AACC) Conference and Clinical Laboratory Expo (ADLM) was successfully held at the McCormick Place Convention Center in Chicago, Illinois, USA.


This prestigious international event brought together top experts from around the world in the fields of clinical chemistry, molecular diagnostics, mass spectrometry, and translational medicine, offering participants a rare opportunity to engage deeply with industry leaders. Over the course of the three-day event, more than 900 leading companies showcased their innovative achievements, including the debut of over 200 groundbreaking new products.


At this year’s exhibition, Rendu Bio’s products once again demonstrated their strong international competitiveness. The highly sensitive quantitative detection of HBV RNA and the STD RNA detection product’s advantages in non-invasive urine sampling and high sensitivity highlighted Rendu Bio’s unique SAT molecular diagnostic technology, addressing the global demand for efficient and precise diagnostic solutions.

The AutoSAT fully automated nucleic acid detection system, with its speed, high throughput, and exceptional accuracy, provides laboratories with more efficient testing solutions. Moreover, the upcoming MiniSAT and SuperSAT devices cater to the needs of laboratories of various scales. These innovations have not only garnered widespread attention in the international market but also earned high praise from overseas customers.


Notably, Rendu Bio made its debut in cancer screening at this year’s exhibition, unveiling innovative products for prostate and bladder cancer detection. This series, based on advanced digital SAT quantitative technology (ddSAT), offers more effective and precise screening for individuals in the PSA gray zone of prostate cancer and those at risk of bladder cancer recurrence post-surgery. These products significantly enhance detection sensitivity and specificity. Both tests utilize non-invasive urine sampling, greatly improving the convenience and comfort of the diagnostic process while minimizing the invasiveness and discomfort associated with traditional methods.


Rendu Bio’s products not only showcase its technological expertise in molecular diagnostics but also reflect the company’s keen market insight and rapid responsiveness to evolving needs. Looking ahead, Rendu Bio remains committed to its mission of "Cherishing Life, Balancing Health."


The company will continue to expand its presence in the international market, striving to become a global leader in the field of molecular diagnostics and contributing to the health of patients worldwide.


Service Hotline +86 400-820-6831
Phone · +86 021-50720200
Address · Building 15B, No. 528 Ruiqing Road, East District, Zhangjiang High tech Park, Shanghai
Email · hr@rdbio.com(Domestic Affairs) sales@rdbio.com(International Trade)